Researchers at Monash Faculty
of Biomedical and Psychological
Sciences studying the oestrogen
receptor GPER found that blocking
it in males up to four hours after a
stroke could alleviate symptoms,
while triggering it in older women
could protect from the effects.
Monash said it was the first time a
drug with this potential in a genderspecific
manner had been found
and was considered “a significant
breakthrough in stroke research.”
The results were published in
Stroke.
Associate professor Chris Sobey
said it was conceivable that a postmenopausal
woman presenting
with a stroke would be treated by
stimulating the receptor through a
target drug while a similarly aged
man would receive a GPER blocker.
To read more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.